News for Actinium Pharmaceuticals Stock (ATNM)

My Top 2 Stock Picks For A 2025 Rebound

Seeking Alpha • 12/11/24

SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

PRNewsWire • 11/19/24

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024

PRNewsWire • 11/18/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Accesswire • 11/04/24

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

PRNewsWire • 11/04/24

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Accesswire • 11/03/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Accesswire • 11/02/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violations Of Securities Laws And Affected Shareholders Should Contact The Schall Law Firm

Accesswire • 10/30/24

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Actinium Pharmaceuticals Inc For Fraud

Accesswire • 10/29/24

The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Accesswire • 10/28/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

Accesswire • 10/27/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Accesswire • 10/25/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Shareholders Are Urged To Reach Out To The Schall Law Firm

Accesswire • 10/21/24

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Accesswire • 10/20/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Related Infractions And Affected Shareholders Are Urged To Contact The Schall Law Firm

Accesswire • 10/19/24

All You Need to Know About Actinium (ATNM) Rating Upgrade to Strong Buy

Zacks Investment Research • 10/18/24

Actineer, a Joint Venture of ITM and CNL, Begins Actinium-225 Production

Business Wire • 10/18/24

The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Accesswire • 10/16/24

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc's Possible Securities Fraud

Accesswire • 10/14/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Accesswire • 10/09/24

The Schall Law Firm Encourages Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Accesswire • 10/08/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Accesswire • 10/05/24

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc's Possible Securities Fraud

Accesswire • 10/02/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Stockholders With Losses Are Urged To Contact The Schall Law Firm

Accesswire • 10/01/24

TerraPower Isotopes Brings Actinium-225 to Market

Business Wire • 10/01/24